Recombinant Human Anti-CEA x Anti-GD2 Bispecific Antibody (Tandem scFv) (BSFV-H307)

Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-CEA antibody variable domains fused with a scFv from an anti-GD2 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can bind two factors simultaneously. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors therapy.

Datasheet INQUIRY

Specifications

Targets

CEA & GD2

Type

Tandem scFv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Neuroblastoma; Osteosarcoma; MelanomaSolid tumors

Targets

Target 1

CEA

Gene ID

1048

UniProt ID

A0A024R0K5

Alternative Names

CEACAM5; carcinoembryonic antigen; carcinoembryonic antigen related cell adhesion molecule 5; CEA; CD66e; meconium antigen 100

Target 2

GD2

Alternative Names

Ganglioside GD2; GD2; Ganglioside; Disialoganglioside GD2

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CEA x Anti-GD2 Bispecific Antibody (Tandem scFv) (BSFV-H307). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CEA x Anti-GD2 Bispecific Antibody (Tandem scFv) (CAT#: BSFV-H307)

Specifications

Targets

Customer Reviews and Q&As